Product Information

PIOGLITAZONE HCL 45 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1163 per EA under NDC 62135080630. Its NADAC has been published 136 times since Apr 10, 2024.

FDA first approved this application on Oct 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE HCL 45 MG TABLET

PIOGLITAZONE HYDROCHLORIDE
$0.1163per EA

Strength

45 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135080630

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076798

FDA Approved

10/26/2012

TE Code

AB

On Market Since

10/28/2020

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 45 MG TABLET has been published 136 times since Apr 10, 2024, and over the history we have for it it has declined 19.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1163 per EA
All-time high$0.1450 (Apr 10, 2024)
All-time low$0.0964 (Nov 20, 2024)
52-week high$0.1213
52-week low$0.1111
Median price$0.1185
Average price$0.1198
Largest weekly change-26.2% (Nov 20, 2024)
Weeks tracked136
Tracking sinceApr 10, 2024

Price History

1W

0.0%

1M

+1.6%

3M

+4.6%

6M

-2.8%

1Y

-5.2%

3Y

N/A

5Y

N/A

All

-19.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PIOGLITAZONE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 45 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 45 MG TABLET, manufactured by Chartwell RX LLC, is $0.1163 per EA (NDC 62135080630), effective Nov 11, 2026.

How has the price of PIOGLITAZONE HCL 45 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has declined 19.8%. It has been tracked across 136 weekly CMS publications since Apr 10, 2024.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 45 MG TABLET?

Since Apr 10, 2024, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has ranged from a low of $0.0964 (Nov 20, 2024) to a high of $0.1450 (Apr 10, 2024), with a median of $0.1185 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 45 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PIOGLITAZONE HCL 45 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PIOGLITAZONE HCL 45 MG TABLET?

PIOGLITAZONE HCL 45 MG TABLET (NDC 62135080630) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.